- Filed
- Aug 13, 2024 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q2 2024 · Aug 13, 2024 | 2.81M sh |
| Capex | Q2 2024 · Jun 30, 2024 | $0 |
| Capex | Q2 2024 · Jun 30, 2023 | $50K |
| Short Term Investments | Q2 2024 · Jun 30, 2024 | $4.94M |
| Short Term Investments | Q2 2024 · Dec 31, 2023 | $4.37M |
| Stockholders Equity | Q2 2024 · Jun 30, 2024 | $31.96M |
| Stockholders Equity | Q2 2024 · Dec 31, 2023 | $32.44M |
| Total Liabilities | Q2 2024 · Jun 30, 2024 | $17.09M |
| Total Liabilities | Q2 2024 · Dec 31, 2023 | $9.48M |
| Total Assets | Q2 2024 · Jun 30, 2024 | $48.94M |
| Total Assets | Q2 2024 · Dec 31, 2023 | $41.9M |
| Cash And Equivalents | Q2 2024 · Dec 31, 2023 | $10.25M |
| Cash And Equivalents | Q2 2024 · Jun 30, 2023 | $8.76M |
| Shares Diluted | Q2 2024 · Jun 30, 2023 | 2.87M sh |
| Shares Diluted | Q2 2024 · Jun 30, 2023 | 2.87M sh |
| Stock Repurchased | Q2 2024 · Jun 30, 2023 | $33K |
| Operating Cash Flow | Q2 2024 · Jun 30, 2023 | $5.91M |
| Eps Diluted | Q2 2024 · Jun 30, 2023 | $0.03 |
| Eps Diluted restated | Q2 2024 · Jun 30, 2023 | −$0.25 |
| Eps Basic | Q2 2024 · Jun 30, 2023 | $0.03 |
| Eps Basic restated | Q2 2024 · Jun 30, 2023 | −$0.25 |
| Sga Expense | Q2 2024 · Jun 30, 2023 | $3.9M |
| Sga Expense | Q2 2024 · Jun 30, 2023 | $6.71M |
| Net Income | Q2 2024 · Jun 30, 2023 | $80K |
| Net Income | Q2 2024 · Jun 30, 2023 | −$719K |
| Gross Profit | Q2 2024 · Jun 30, 2023 | $3.53M |
| Gross Profit | Q2 2024 · Jun 30, 2023 | $5.27M |
| Cost Of Revenue | Q2 2024 · Jun 30, 2023 | $175K |
| Cost Of Revenue | Q2 2024 · Jun 30, 2023 | $380K |
| Revenue | Q2 2024 · Jun 30, 2023 | $3.71M |
| Revenue | Q2 2024 · Jun 30, 2023 | $5.65M |